These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1375 related items for PubMed ID: 22726451
1. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities? Gigante M, Neuzillet Y, Patard JJ, Tillou X, Thuret R, Branchereau J, Timsit MO, Terrier N, Boutin JM, Sallusto F, Karam G, Barrou B, Chevallier D, Mazzola CR, Delaporte V, Doeffler A, Kleinclauss F, Badet L, members of the Comité de Cancerologie de l'Association Française d'Urologie (CCAFU), Comité de Transplantation de l'Association Française d'Urologie (CTAFU). BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451 [Abstract] [Full Text] [Related]
2. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Neuzillet Y, Tillou X, Mathieu R, Long JA, Gigante M, Paparel P, Poissonnier L, Baumert H, Escudier B, Lang H, Rioux-Leclercq N, Bigot P, Bernhard JC, Albiges L, Bastien L, Petit J, Saint F, Bruyere F, Boutin JM, Brichart N, Karam G, Branchereau J, Ferriere JM, Wallerand H, Barbet S, Elkentaoui H, Hubert J, Feuillu B, Theveniaud PE, Villers A, Zini L, Descazeaux A, Roupret M, Barrou B, Fehri K, Lebret T, Tostain J, Terrier JE, Terrier N, Martin L, Dugardin F, Galliot I, Staerman F, Azemar MD, Irani J, Tisserand B, Timsit MO, Sallusto F, Rischmann P, Guy L, Valeri A, Deruelle C, Azzouzi AR, Chautard D, Mejean A, Salomon L, Rigaud J, Pfister C, Soulié M, Kleinclauss F, Badet L, Patard JJ, Comité de Transplantation de l'Association Française d'Urologie, Comité de Cancérologie de l'Association Française d'Urologie. Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780 [Abstract] [Full Text] [Related]
4. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V, Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project, Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation. BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519 [Abstract] [Full Text] [Related]
5. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV. Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127 [Abstract] [Full Text] [Related]
8. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population. Breda A, Lucarelli G, Rodriguez-Faba O, Guirado L, Facundo C, Bettocchi C, Gesualdo L, Castellano G, Grandaliano G, Battaglia M, Palou J, Ditonno P, Villavicencio H. World J Urol; 2015 Jan; 33(1):1-7. PubMed ID: 24504760 [Abstract] [Full Text] [Related]
17. Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma. Kawaciuk I, Hyrsl L, Dusek P, Jarolim L, Schmidt M, Kaliska V, Chocholaty M, Vesely S. Scand J Urol Nephrol; 2008 Jan; 42(5):406-11. PubMed ID: 18932106 [Abstract] [Full Text] [Related]